1. Test the ability of botulinum toxin type A, when injected into the surgical incision at the time of surgery, to decrease postoperative scar scores compared to control (normal saline) in a double-blinded randomized control trial. 2. Investigate the mechanism of BTXa effects of scar formation by measuring micro RNA profiles at two time points in the healing process.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Modified Patient and Observer Scar Assessment Scale v2.0 (POSAS)
Timeframe: Photos will be reviewed at the 1 week follow surgery
Modified Patient and Observer Scar Assessment Scale v2.0 (POSAS)
Timeframe: 4-8 weeks following surgery
Modified Patient and Observer Scar Assessment Scale v2.0 (POSAS)
Timeframe: 6 month mark following surgery